SEC Form 4 · accession 0001209191-18-064107
Entasis Therapeutics Holdings Inc. · ETTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ruben Tommasi
Officer — Chief Scientific Officer
Period of report
Dec 21, 2018
Accepted (ET)
Dec 26, 2018 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724344
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2018 | M | 11,788 | $3.74 | A | 11,788 | D | |
| Common Stock | Dec 21, 2018 | M | 10,236 | $3.11 | A | 22,024 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.74 | Dec 21, 2018 | M | 11,788 | D | — | Oct 21, 2026 | Common Stock | 11,788 | 6,465 | D |
| Employee Stock Option (Right to Buy)F2 | $3.11 | Dec 21, 2018 | M | 10,236 | D | — | Nov 21, 2027 | Common Stock | 10,236 | 24,858 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the last day of the month, subject to Reporting Person continuing to provide service through each such date.
- F2Twenty-five percent (25%) of the shares subject to the option vested on August 25, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the last day of the month, subject to Reporting Person continuing to provide service through each such date.